Trial Profile
A Single-Dose Pharmacokinetics Study of Tapimycin Injection(Piperacillin 4 g + Tazobactam 0.5 g Powder for Injection) Administered Under Fasting Conditions to Healthy Adult Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 18 Dec 2009
Price :
$35
*
At a glance
- Drugs Piperacillin/tazobactam (Primary)
- Indications Bacterial infections; Infections
- Focus Pharmacokinetics
- 22 Jun 2009 New trial record